BioVentures Investors closes Fund IV at USD8m
BioVentures Investors has held the closing of its fourth fund at USD87 million. The Wellesley, Massachusetts, venture fund will invest in high-value-added medical technology enterprises (MedTech) such as medical devices and diagnostics. The fund’s focus is on technology with the potential to provide important benefits to patients, physicians and